Clinical trial
Immunomodulatory Properties of Ketamine in Sepsis
NCT01089361 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Immunomodulatory Properties of Ketamine in Sepsis
- Lead sponsor
- Beth Israel Deaconess Medical Center
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- December 31, 2009
- Completion date
- June 30, 2011
- Enrollment
- 19 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.